Back to Agenda
Session 4: High-Quality Real World Data (RWD) in Decision Making
Session Chair(s)
Susan Longman
Head Regulatory Affairs Region Europe , Novartis Pharma AG, Switzerland
Session 4: High-Quality Real World Data (RWD) in Decision Making
Speaker(s)
Registry Initiatives Across Europe
Xavier Kurz, MD, PhD, MSc
Head of Data Analytics Workstream, European Medicines Agency, Netherlands
Karin Van Baelen, PharmD
Head, Global Regulatory Affairs, Janssen, Belgium
Trusting the Data: Quality, Ethics, Privacy
Jesper Kjær, MS
Director for Public, Private Partnerships - Science, Policy & Intelligence, Novo Nordisk A/S, Denmark
Have an account?